NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 70 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q4 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $87,000 | -35.6% | 249,625 | 0.0% | 0.01% | -40.0% |
| Q3 2016 | $135,000 | +419.2% | 249,625 | +450.1% | 0.02% | +400.0% |
| Q2 2016 | $26,000 | -60.6% | 45,375 | 0.0% | 0.00% | -60.0% |
| Q1 2016 | $66,000 | -54.5% | 45,375 | 0.0% | 0.01% | -58.3% |
| Q4 2015 | $145,000 | -48.9% | 45,375 | 0.0% | 0.02% | -52.0% |
| Q3 2015 | $284,000 | -14.2% | 45,375 | +36.0% | 0.05% | -5.7% |
| Q2 2015 | $331,000 | +3.4% | 33,375 | -23.1% | 0.05% | +3.9% |
| Q1 2015 | $320,000 | +44.8% | 43,375 | +4.8% | 0.05% | +41.7% |
| Q4 2014 | $221,000 | +6.2% | 41,375 | 0.0% | 0.04% | +2.9% |
| Q3 2014 | $208,000 | -25.2% | 41,375 | 0.0% | 0.04% | -25.5% |
| Q2 2014 | $278,000 | +2.6% | 41,375 | +10.7% | 0.05% | -4.1% |
| Q1 2014 | $271,000 | +83.1% | 37,375 | -5.1% | 0.05% | +81.5% |
| Q4 2013 | $148,000 | +117.6% | 39,375 | +93.3% | 0.03% | +107.7% |
| Q3 2013 | $68,000 | 0.0% | 20,375 | 0.0% | 0.01% | -7.1% |
| Q2 2013 | $68,000 | – | 20,375 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 9,379,987 | $69,131,000 | 9.82% |
| Family Management Corp | 82,875 | $611,000 | 0.28% |
| Montecito Bank & Trust | 75,717 | $558,000 | 0.28% |
| Bedell Frazier Investment Counselling, LLC | 62,825 | $463,000 | 0.19% |
| Lyons Wealth Management, LLC. | 20,000 | $147,000 | 0.16% |
| Price Capital Management, Inc. | 28,864 | $213,000 | 0.13% |
| BOLTON LP | 50,000 | $369,000 | 0.10% |
| BOLTON LP | 50,000 | $369,000 | 0.10% |
| WEDBUSH SECURITIES INC | 76,500 | $564,000 | 0.10% |
| HYMAN CHARLES D | 43,375 | $320,000 | 0.05% |